The success of the EGFR and VEGFR pathway antagonists in treatment of metastatic NSCLC has important implications for development of novel targeted therapies such as the PKC inhibitors.

EGFR和VEGFR途径拮抗剂在治疗转移性NSCLC中的成功对开发一种新的靶向治疗药物如PKC抑制剂具有重要意义。

youdao

The process identified in this study could offer a promising target for the development of new treatments to prevent the further spread of metastatic cancer.

搞清楚这一过程，为我们提供了一个很有用的靶向目标，可以用于开发研制治疗和防止肿瘤进一步扩散的药物和手段。

youdao

The model also suggested that an anti-inflammatory drug called celecoxib should bind with CDH11, a protein which plays an important role in the development of both rheumatoid arthritis and metastatic breast cancer.

ECONOMIST: Computers may give new life to old medicines

Kadcyla, known as an "antibody-drug conjugate, " represents "a completely new way" to treat HER2 positive metastatic breast cancer, said Dr. Hal Barron, chief medical officer and head of global product development for Genentech.

CNN: New late-stage breast cancer treatment approved